Skip to main content
Clinical Trials/JPRN-UMIN000008311
JPRN-UMIN000008311
Completed
Phase 4

Clinical investigation of upper gastrointestinal mucosal injury in patients receiving antiplatelet agents as a single agent or in combination: A randomaized control study in healthy volunteers. - Upper gastrointestinal mucosal injury by antiplatelet agents

Hyogo College of Medicine0 sites32 target enrollmentJuly 1, 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
pper gastrointestinal mucosal injury by antiplatelet agents
Sponsor
Hyogo College of Medicine
Enrollment
32
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2012
End Date
October 1, 2012
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • a. Presence of diseases with a bleeding tendency b. Previous hypersensitivity for ingredient of aspirin c.Severe comorbidities (including malignant tumor, liver cirrhosis, renal failure, and cardiac failure) d. With no regular use of medicine e.Individuals judged by investigators as ineligible for study enrollment.

Outcomes

Primary Outcomes

Not specified

Similar Trials